JULIANNE MACMULLEN: Open Payments
NPI 1053044107 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 44 payments from 11 companies in 2025. Trend: 2023 $2,859 · 2024 $1,265 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 30 | $399 |
| ABBVIE INC. | 3 | $74 |
| Medtronic, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Curonix LLC | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
Products named: Belbuca, XTAMPZA, EPKINLY, IMBRUVICA, SCEMBLIX, QINLOCK, SYNCHROMEDII, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A.
Industry payments across CA — which companies pay providers there.
